News archive for Translational Cancer Research
Bortezomib as chemosensitizer for glioblastoma patients with unmethylated MGMT promoter: Phase IB/II clinical trial and mechanisms of therapeutic efficacy
- March 2021 (1)
- October 2020 (2)
- September 2020 (1)
- April 2020 (1)
- September 2019 (1)
- February 2019 (1)
- January 2019 (1)
- December 2018 (1)
- November 2018 (1)
- July 2018 (1)
- April 2018 (2)
- February 2018 (1)
- November 2017 (1)
- July 2016 (1)
- December 2014 (1)